Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clostridium Butyricum for IBS
NCT02614963Phase 4Unknown
- Sponsor
- Shandong University
- Start
- Dec 2015
- Primary completion
- Jul 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 4 trial of clostridium butyricum in irritable bowel syndrome (IBS), sponsored by Shandong University. Status: unknown.
02
Drugs
clostridium butyricum
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT02614963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02614963.